Takami Sato, MD,PhD

Contact Dr. Sato

925 Chestnut Street
Suite 320A
Philadelphia, PA 19107

(215) 955-8874

Medical School
Jichi Medical University, Japan - 1980

Residency
Oita Prefectural Hospital, Japan

Fellowship
Jichi Medical University, Japan

Board Certification
Pediatrics

Hospital Appointment
Thomas Jefferson University Hospital
Methodist Hospital Division of Thomas Jefferson University Hospital

Hospital Appointment
Active Medical Staff
Director, Metastatic Uveal Melanoma Program

University Appointment
Professor of Medical Oncology

Research and Clinical Interests
Medical Oncology, Melanoma, Skin Cancer, Uveal Melanoma, Ocular Melanoma, Cancer Immunotherapy

Publications

Most recent Peer-reviewed Publications

1. Transhepatic therapies for metastatic uveal melanoma
2. Somatostatin receptor scintigraphy in patients with metastatic uveal melanoma
3. A pilot study of sunitinib malate in patients with metastatic uveal melanoma
4. Pseudo-spherical evolutes of curves on a spacelike surface in three dimensional Lorentz-Minkowski space
5. Uveal melanoma trapped in the temple of doom
6. Interleukin 6 mediates production of interleukin 10 in metastatic melanoma
7. Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma
8. Interleukin 10 in the tumor microenvironment: A target for anticancer immunotherapy
9. Toxicities after radioembolization with yttrium-90 SIR-spheres: Incidence and contributing risk factors at a single center
10. Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: A pilot study
11. Side-branch embolization before 90Y radioembolization: Rate of recanalization and new collateral development
12. Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine
13. Conjunctival melanoma: Bladder and upper urinary tract metastases
14. Mind the BAP
15. Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: A single-institution experience
16. Summary and assessment
17. A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma
18. Surgically unresectable regional melanoma metastases in a patient with renal failure and peripheral vascular disease: Are there safe and potentially effective treatments?
19. Locoregional Management of Hepatic Metastasis From Primary Uveal Melanoma
20. Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: Immunoadhesins for human IL-10 with therapeutic potential

View All Publications